|

AZD9592 Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Early 1: 1Phase 1: 1

Top Sponsors

  • Presage Biosciences1
  • AstraZeneca1

Indications

  • Cancer2
  • Advanced Solid Tumours1
  • Carcinoma, Non-Small-Cell Lung1
  • Colorectal Neoplasms1
  • Head and Neck Neoplasms1

Duarte, California1 trial

First in Human Study of AZD9592 in Solid Tumors

Research Site

Phase 1

Sacramento, California1 trial

PBI-MST-01 (NCT04541108) Substudy AZN-05: Intratumoral Microdosing of Rilvegostomig, Volrustomig, Sabestomig, and AZD9592 in HNSCC

UC Davis

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.